Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Damian

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Autoimmunity Reviews|April 3, 2020
In utero exposure to Azathioprine in autoimmune disease. Where do we stand?Cristina Belizna, Pier Luigi Meroni, Yehuda Shoenfeld, et al.
Clinical and Experimental Rheumatology|March 14, 2023
ERN ReCONNET points to consider for treating patients living with autoimmune rheumatic diseases with antiviral therapies and anti-SARS-CoV-2 antibody productsRosaria Talarico, Giuseppe Alvise Ramirez, Sofia C Barreira, et al.
Journal of Scleroderma and Related Disorders|November 15, 2024
Improving organisation to improve care: ERN ReCONNET organisational reference model for systemic sclerosis patients' care pathwayRosaria Talarico, Diana Marinello, Ilaria Palla, et al.
Autoimmunity Reviews|October 15, 2018
HIBISCUS: Hydroxychloroquine for the secondary prevention of thrombotic and obstetrical events in primary antiphospholipid syndromeCristina Belizna, Francesca Pregnolato, Sebastien Abad, et al.
Clinical and Experimental Rheumatology|February 24, 2022
Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodiesLorenzo Cavagna, Federica Meloni, Alain Meyer, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Autoimmunity Reviews|April 3, 2020
In utero exposure to Azathioprine in autoimmune disease. Where do we stand?Cristina Belizna, Pier Luigi Meroni, Yehuda Shoenfeld, et al.
Clinical and Experimental Rheumatology|March 14, 2023
ERN ReCONNET points to consider for treating patients living with autoimmune rheumatic diseases with antiviral therapies and anti-SARS-CoV-2 antibody productsRosaria Talarico, Giuseppe Alvise Ramirez, Sofia C Barreira, et al.
Journal of Scleroderma and Related Disorders|November 15, 2024
Improving organisation to improve care: ERN ReCONNET organisational reference model for systemic sclerosis patients' care pathwayRosaria Talarico, Diana Marinello, Ilaria Palla, et al.
Autoimmunity Reviews|October 15, 2018
HIBISCUS: Hydroxychloroquine for the secondary prevention of thrombotic and obstetrical events in primary antiphospholipid syndromeCristina Belizna, Francesca Pregnolato, Sebastien Abad, et al.
Clinical and Experimental Rheumatology|February 24, 2022
Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodiesLorenzo Cavagna, Federica Meloni, Alain Meyer, et al.
Pageof 5